LAURA HOLZMER: Open Payments
NPI 1366805293 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 32 payments from 12 companies in 2025. Trend: 2023 $473 · 2024 $541 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 4 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $98 |
| Actelion Pharmaceuticals US, Inc. | 3 | $96 |
| Grifols USA, LLC | 3 | $93 |
| Viatris Specialty LLC | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Electromed, Inc. | 3 | $62 |
| United Therapeutics Corporation | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
Products named: Ohtuvayre, OFEV, Prolastin-C Liquid, YUPELRI, OPSUMIT, SMARTVEST, Tyvaso, DUPIXENT.
Industry payments across TN — which companies pay providers there.
